Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC01233 (long intergenic non-protein coding RNA 1233) is a human long non-coding RNA (lncRNA) gene encoded at locus HGNC:49756, located on chromosome 19p12 (GRCh38/hg38)[1][5][7][9][12]. It is a transcribed RNA molecule that does not encode a protein and instead likely participates in regulatory processes such as gene expression modulation, consistent with broad lncRNA functions[9][11]. LINC01233 is not a receptor, enzyme, transporter, or transcription factor, and is generally not considered a direct therapeutic target[9][11]. The gene is sometimes referenced in cancer research, particularly as part of genomic expression or as a putative modifier, but no drugs or targeted therapies have been described to interact specifically with LINC01233, nor is it listed as a validated biomarker or therapeutic target in clinical sources[9][11][12]. Summary of context and conventions - The gene is correctly named and not misspelled nor incorrectly characterized[3][5]. - Alternative designation XLOC_013014 is a database reference alias[5][7]. - Not classified as a receptor, enzyme, transporter, transcription factor, or any classical druggable molecular class[1][5][7][9]. - Disease associations are mainly correlative/research-based rather than causative or actionable[2][12]. - Safety concerns, mechanisms of drug action, and direct drug interactions do not apply to this lncRNA as of available knowledge[9][11][12].
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1233 (LINC01233).